Yuyu Pharma unveils the results of its studies for its dry eye treatment peptide
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
Granules now have a total of 53 ANDA approvals from USFDA
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
The ninth acquisition since 2018
She joins Enveda from Gilead Sciences
Huntington Medical Research Institutes present first-of-its-kind study examining impact of erectile dysfunction drugs on major adverse cardiovascular events and mortality
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise
The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy
Subscribe To Our Newsletter & Stay Updated